SOUTHWEST ONCOLOGY GROUP

参与多学科的设计方法， 进行恶性疾病的临床试验。 这些疾病包括 成人实体瘤、淋巴瘤、多发性骨髓瘤、白血病和其他 肿瘤将由西南肿瘤组进行研究。 这些研究将被归类为I期，用于评价 毒性、耐受剂量和治疗范围 第二阶段，以确定发生的频率、程度和持续时间 缓解与新的药物;和第三阶段，以建立相对 各种治疗方案在肿瘤疾病中的功效。 为了研究一些生物化学和生物学方面的问题， 研究中的肿瘤，因为它们来自可用于 合作研究。 积极参与并为集团的整体工作做出贡献。 这将包括科学投入、方案设计方面的支持， 主持研究和要求的行政任务。

To participate in the multidisciplinary approach to the design and conduct of clinical trials in malignant diseases. These diseases include adult solid tumors, lymphoma, multiple myeloma, leukemia, and other neoplasms to be studies by the Southwest Oncology Group. These studies will be classified as phase I for the evaluation of toxicity, tolerated dosage and therapeutic range of new combinations of agents; phase II to determine the frequency, extent and duration of remission with new agents; and phase III to establish the relative efficacy of various therapeutic regimens in neoplastic diseases. To investigate some of the biochemical and biological aspects of the neoplasms under study as they derive from patient material available for the cooperative studies. To actively participate in and contribute to the overall Group effort. This will include scientific input, support in protocol design, chairmanship of studies and requested administrative tasks.